Rhythm Pharmaceuticals (RYTM) Research & Development: 2020-2025
Historic Research & Development for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Sep 2025 value amounting to $46.0 million.
- Rhythm Pharmaceuticals' Research & Development rose 21.34% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.5 million, marking a year-over-year decrease of 26.56%. This contributed to the annual value of $238.0 million for FY2024, which is 76.33% up from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Research & Development of $46.0 million as of Q3 2025, which was up 8.79% from $42.3 million recorded in Q2 2025.
- Rhythm Pharmaceuticals' 5-year Research & Development high stood at $128.7 million for Q1 2024, and its period low was $19.9 million during Q1 2021.
- Over the past 3 years, Rhythm Pharmaceuticals' median Research & Development value was $37.9 million (recorded in 2024), while the average stood at $45.3 million.
- Its Research & Development has fluctuated over the past 5 years, first spiked by 239.08% in 2024, then tumbled by 71.26% in 2025.
- Rhythm Pharmaceuticals' Research & Development (Quarterly) stood at $31.6 million in 2021, then decreased by 25.42% to $23.5 million in 2022, then grew by 26.94% to $29.9 million in 2023, then surged by 37.72% to $41.2 million in 2024, then increased by 21.34% to $46.0 million in 2025.
- Its last three reported values are $46.0 million in Q3 2025, $42.3 million for Q2 2025, and $37.0 million during Q1 2025.